Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1997 Oct;61(4):945–952. doi: 10.1086/514873

Risk reversals in predictive testing for Huntington disease.

E Almqvist 1, S Adam 1, M Bloch 1, A Fuller 1, P Welch 1, D Eisenberg 1, D Whelan 1, D Macgregor 1, W Meschino 1, M R Hayden 1
PMCID: PMC1715985  PMID: 9382108

Abstract

The first predictive testing for Huntington disease (HD) was based on analysis of linked polymorphic DNA markers to estimate the likelihood of inheriting the mutation for HD. Limits to accuracy included recombination between the DNA markers and the mutation, pedigree structure, and whether DNA samples were available from family members. With direct tests for the HD mutation, we have assessed the accuracy of results obtained by linkage approaches when requested to do so by the test individuals. For six such individuals, there was significant disparity between the tests. Three went from a decreased risk to an increased risk, while in another three the risk was decreased. Knowledge of the potential reasons for these changes in results and impact of these risk reversals on both patients and the counseling team can assist in the development of strategies for the prevention and, where necessary, management of a risk reversal in any predictive testing program.

Full text

PDF
945

Images in this article

946Figure 1
on p.946
947Figure 2
on p.947
949Figure 3
on p.949
949Figure 4
on p.949
950Figure 5
on p.950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird S. J. Presymptomatic testing for Huntington's disease. JAMA. 1985 Jun 14;253(22):3286–3291. [PubMed] [Google Scholar]
  2. Bloch M., Adam S., Wiggins S., Huggins M., Hayden M. R. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk. Am J Med Genet. 1992 Feb 15;42(4):499–507. doi: 10.1002/ajmg.1320420416. [DOI] [PubMed] [Google Scholar]
  3. Bloch M., Fahy M., Fox S., Hayden M. R. Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet. 1989 Feb;32(2):217–224. doi: 10.1002/ajmg.1320320215. [DOI] [PubMed] [Google Scholar]
  4. Brinkman R. R., Mezei M. M., Theilmann J., Almqvist E., Hayden M. R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am J Hum Genet. 1997 May;60(5):1202–1210. [PMC free article] [PubMed] [Google Scholar]
  5. Chong S. S., Almqvist E., Telenius H., LaTray L., Nichol K., Bourdelat-Parks B., Goldberg Y. P., Haddad B. R., Richards F., Sillence D. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses. Hum Mol Genet. 1997 Feb;6(2):301–309. doi: 10.1093/hmg/6.2.301. [DOI] [PubMed] [Google Scholar]
  6. Craufurd D. I., Harris R. Ethics of predictive testing for Huntington's chorea: the need for more information. Br Med J (Clin Res Ed) 1986 Jul 26;293(6541):249–251. doi: 10.1136/bmj.293.6541.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farrer L. A. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. Am J Med Genet. 1986 Jun;24(2):305–311. doi: 10.1002/ajmg.1320240211. [DOI] [PubMed] [Google Scholar]
  8. Foulkes W. D., Narod S. A. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing. Clin Invest Med. 1995 Dec;18(6):473–483. [PubMed] [Google Scholar]
  9. Fox S., Bloch M., Fahy M., Hayden M. R. Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia. Am J Med Genet. 1989 Feb;32(2):211–216. doi: 10.1002/ajmg.1320320214. [DOI] [PubMed] [Google Scholar]
  10. Gilliam T. C., Bucan M., MacDonald M. E., Zimmer M., Haines J. L., Cheng S. V., Pohl T. M., Meyers R. H., Whaley W. L., Allitto B. A. A DNA segment encoding two genes very tightly linked to Huntington's disease. Science. 1987 Nov 13;238(4829):950–952. doi: 10.1126/science.2890209. [DOI] [PubMed] [Google Scholar]
  11. Goldberg Y. P., Andrew S. E., Clarke L. A., Hayden M. R. A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington disease. Hum Mol Genet. 1993 Jun;2(6):635–636. doi: 10.1093/hmg/2.6.635. [DOI] [PubMed] [Google Scholar]
  12. Goldberg Y. P., McMurray C. T., Zeisler J., Almqvist E., Sillence D., Richards F., Gacy A. M., Buchanan J., Telenius H., Hayden M. R. Increased instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population. Hum Mol Genet. 1995 Oct;4(10):1911–1918. doi: 10.1093/hmg/4.10.1911. [DOI] [PubMed] [Google Scholar]
  13. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  14. Hayden M. R., Robbins C., Allard D., Haines J., Fox S., Wasmuth J., Fahy M., Bloch M. Improved predictive testing for Huntington disease by using three linked DNA markers. Am J Hum Genet. 1988 Nov;43(5):689–694. [PMC free article] [PubMed] [Google Scholar]
  15. Huggins M., Bloch M., Wiggins S., Adam S., Suchowersky O., Trew M., Klimek M., Greenberg C. R., Eleff M., Thompson L. P. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet. 1992 Feb 15;42(4):508–515. doi: 10.1002/ajmg.1320420417. [DOI] [PubMed] [Google Scholar]
  16. Kessler S. Psychiatric implications of presymptomatic testing for Huntington's disease. Am J Orthopsychiatry. 1987 Apr;57(2):212–219. doi: 10.1111/j.1939-0025.1987.tb03531.x. [DOI] [PubMed] [Google Scholar]
  17. Kremer B., Almqvist E., Theilmann J., Spence N., Telenius H., Goldberg Y. P., Hayden M. R. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. Am J Hum Genet. 1995 Aug;57(2):343–350. [PMC free article] [PubMed] [Google Scholar]
  18. Kremer B., Goldberg P., Andrew S. E., Theilmann J., Telenius H., Zeisler J., Squitieri F., Lin B., Bassett A., Almqvist E. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994 May 19;330(20):1401–1406. doi: 10.1056/NEJM199405193302001. [DOI] [PubMed] [Google Scholar]
  19. Pelias M. Z. Duty to disclose in medical genetics: a legal perspective. Am J Med Genet. 1991 Jun 1;39(3):347–354. doi: 10.1002/ajmg.1320390320. [DOI] [PubMed] [Google Scholar]
  20. Radford D. M., Zehnbauer B. A. Inherited breast cancer. Surg Clin North Am. 1996 Apr;76(2):205–220. doi: 10.1016/s0039-6109(05)70434-5. [DOI] [PubMed] [Google Scholar]
  21. Rubinsztein D. C., Leggo J., Coles R., Almqvist E., Biancalana V., Cassiman J. J., Chotai K., Connarty M., Crauford D., Curtis A. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet. 1996 Jul;59(1):16–22. [PMC free article] [PubMed] [Google Scholar]
  22. Sandelin K., Larsson C., Decker R. A. Genetic aspects of multiple endocrine neoplasia types 1 and 2. Curr Opin Gen Surg. 1994:60–68. [PubMed] [Google Scholar]
  23. Smurl J. F., Weaver D. D. Presymptomatic testing for Huntington chorea: guidelines for moral and social accountability. Am J Med Genet. 1987 Feb;26(2):247–257. doi: 10.1002/ajmg.1320260203. [DOI] [PubMed] [Google Scholar]
  24. Verschuuren-Bemelmans C. C., Brunt E. R., Burton M., Mensink R. G., van der Meulen M. A., Smit N. H., Stolte-Dijkstra I., Buys C. H., Scheffer H. Refinement by linkage analysis in two large families of the candidate region of the third locus (SCA3) for autosomal dominant cerebellar ataxia type I. Hum Genet. 1995 Dec;96(6):691–694. doi: 10.1007/BF00210301. [DOI] [PubMed] [Google Scholar]
  25. Wasmuth J. J., Hewitt J., Smith B., Allard D., Haines J. L., Skarecky D., Partlow E., Hayden M. R. A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature. 1988 Apr 21;332(6166):734–736. doi: 10.1038/332734a0. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES